ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
130.2 EUR
+0.8 (+0.62%)
ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 74 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT has a decent growth rate and is not valued too expensively. With these ratings, ACT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
In the past 5 years ACT has always been profitable.
Of the past 5 years ACT 4 years had a positive operating cash flow.
1.2 Ratios
ACT has a better Return On Assets (10.49%) than 95.95% of its industry peers.
With an excellent Return On Equity value of 26.47%, ACT belongs to the best of the industry, outperforming 95.95% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.45%, ACT belongs to the top of the industry, outperforming 93.24% of the companies in the same industry.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.87%.
The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a Profit Margin of 10.97%. This is amongst the best in the industry. ACT outperforms 83.78% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
ACT's Operating Margin of 15.93% is amongst the best of the industry. ACT outperforms 85.14% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
Looking at the Gross Margin, with a value of 66.55%, ACT belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACT has an improved debt to assets ratio.
2.2 Solvency
ACT has an Altman-Z score of 4.60. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT has a Altman-Z score of 4.60. This is amongst the best in the industry. ACT outperforms 85.14% of its industry peers.
The Debt to FCF ratio of ACT is 1.32, which is an excellent value as it means it would take ACT, only 1.32 years of fcf income to pay off all of its debts.
ACT has a Debt to FCF ratio of 1.32. This is amongst the best in the industry. ACT outperforms 94.59% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
ACT has a Debt to Equity ratio of 0.16. This is in the better half of the industry: ACT outperforms 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 4.6 |
ROIC/WACC1.9
WACC7.07%
2.3 Liquidity
A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
ACT has a better Current ratio (2.87) than 83.78% of its industry peers.
ACT has a Quick Ratio of 1.77. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
ACT's Quick ratio of 1.77 is amongst the best of the industry. ACT outperforms 81.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
Measured over the past years, ACT shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.60% on average per year.
ACT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.05%.
Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
The Earnings Per Share is expected to grow by 20.26% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.34 indicates a rather expensive valuation of ACT.
ACT's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.15, ACT is valued at the same level.
ACT is valuated rather expensively with a Price/Forward Earnings ratio of 18.66.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.22, ACT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.34 | ||
| Fwd PE | 18.66 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.88 | ||
| EV/EBITDA | 11.05 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
ACT's earnings are expected to grow with 19.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.17
PEG (5Y)0.87
EPS Next 2Y17.04%
EPS Next 3Y19.49%
5. Dividend
5.1 Amount
ACT has a Yearly Dividend Yield of 1.37%.
Compared to an average industry Dividend Yield of 3.13, ACT has a dividend in line with its industry peers.
With a Dividend Yield of 1.37, ACT pays less dividend than the S&P500 average, which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.37% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
ACT pays out 49.16% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
FRA:ACT (12/3/2025, 11:45:57 AM)
130.2
+0.8 (+0.62%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.33B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts81.82
Price Target157.34 (20.84%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.37% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.59%
PT rev (3m)9.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.7%
EPS NY rev (3m)1.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.34 | ||
| Fwd PE | 18.66 | ||
| P/S | 2.35 | ||
| P/FCF | 37.88 | ||
| P/OCF | 9.11 | ||
| P/B | 5.67 | ||
| P/tB | 5.76 | ||
| EV/EBITDA | 11.05 |
EPS(TTM)6.1
EY4.69%
EPS(NY)6.98
Fwd EY5.36%
FCF(TTM)3.44
FCFY2.64%
OCF(TTM)14.3
OCFY10.98%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.17
PEG (5Y)0.87
Graham Number56.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROCE | 18.66% | ||
| ROIC | 13.45% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 16.26% | ||
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% | ||
| FCFM | 6.21% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.34% | ||
| Profit Quality | 56.58% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 4.6 |
F-Score6
WACC7.07%
ROIC/WACC1.9
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 21.34 and the Price/Book (PB) ratio is 5.67.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.